Trastuzumab Completed Phase 2 Trials for Carcinoma, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00043394CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer